New Jersey-based Kenvue Inc. (KVUE) is a consumer health company operating across the Americas, Europe, EMEA, and the Indo-Pacific. It operates through Self Care, Skin Health and Beauty, and Essential Health segments. With a market cap of $28.7 billion, Kenvue owns several well-known brands like Listerine, BAND-AID, Tylenol, Neutrogena, and more.
The household and personal products giant is expected to announce its third-quarter results by early November. Ahead of the event, analysts expect KVUE to report an adjusted EPS of $0.27, down 3.6% from $0.28 reported in the year-ago quarter. On a positive note, the company has a robust earnings surprise history. It has met or surpassed the Street’s bottom-line estimates in each of the past four quarters.
